Introduction
The intestinal microbiota (IM) is believed to play a central role in health, and several studies now link IM dysbiosis to the genesis, emergence, and severity of Crohn's disease (CD). Both quantitative and qualitative dysbioses have been reported in CD. However, the study of IM in CD is unprecedented in Tunisia and across the Maghreb.
Aims & Methods
The aim of our study was to describe the composition and characteristics of the intestinal microbiota in CD and to identify factors associated with dysbiosis.
A prospective study conducted at the Gastroenterology Department of Habib Thameur Hospital (HTH) was conducted from June 2020 to March 2021. All patients with CD followed in outpatient clinics or hospitalized, along with a control group for comparative analysis were included. We excluded patients with ulcerative colitis, unclassified colitis, neoplastic diseases (notably colorectal cancer), severe organ failure (liver, kidney, heart, lungs), or those who had taken antibiotics within three months prior to inclusion. Each patient and control provided a stool sample at the time of enrollment.
DNA extraction was performed and analyzed using a next-generation sequencing (NGS) platform for targeted 16S metagenomics according to a specific MTA. The composition and diversity of the gut microbiota bacterial communities were studied after bioinformatic analysis of the sequences in. A descriptive and analytical statistical analysis (univariate and multivariate logistic regression) was performed to investigate and quantify potential intestinal dysbiosis and to identify factors that may influence the gut microbiota. Approval was obtained from the Biomedical Ethics Committee of the Pasteur Institute of Tunis.
Results
Of the 54 patients included, 16S analysis was possible in 41 patients. The study included 24 men and 17 women with a mean age of 34 years ± 14 [17-67]. The median disease duration was 7 years [2 months – 34 years]. The patients had a mean BMI of 21.7 kg/m² [14-30]. The control group consisted of ten women with a mean age between 20 and 40 years in apparent good health.
After 16S microscopy analysis, we observed a loss of bacterial diversity with a Shannon index ranging from 2 to 6.5 (mean Shannon index < control, p=0.0001). Analysis of the relative abundance of phyla showed a decrease in Firmicutes (Faecalibacterium, Blautia, Dorea) and an increase in Bacteroidetes (Bacteroides and Provotella) in the Crohn's disease population, as well as an increase in Proteobacteria and Fusobacteriota. The analytical study identified three factors associated with lower diversity (Shannon index): history of surgery (p=0.0006), postoperative recurrence (p=0.01), and antibiotic use (p=0.02). No differences were noted regarding age, sex, BMI, duration of disease, location, number of flare-ups, or current medication.
Conclusion
The study confirms a marked dysbiosis in Tunisian Crohn's disease patients, characterized by reduced microbial diversity, a decrease in beneficial Firmicutes, and an expansion of pro-inflammatory bacteria. These findings suggest that monitoring intestinal microbiota could serve as a biomarker for disease activity and inform personalized therapeutic strategies like probiotics or fecal transplantation.
Disclosure
No conflicts of interest are to declare